Després JP - Search Results

1

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.

Després JP, Cartier A, Côté M, Arsenault BJ. Després JP, et al. Ann Med. 2008;40(7):514-23. doi: 10.1080/07853890802004959. Ann Med. 2008. PMID: 18608131 Free article. Review.

2

[Fat distribution and metabolism].

Després JP, Lemieux I, Tchernof A, Couillard C, Pascot A, Lemieux S. Després JP, et al. Diabetes Metab. 2001 Apr;27(2 Pt 2):209-14. Diabetes Metab. 2001. PMID: 11452212 Review. French.

3

Health consequences of visceral obesity.

Després JP. Després JP. Ann Med. 2001 Nov;33(8):534-41. doi: 10.3109/07853890108995963. Ann Med. 2001. PMID: 11730160 Free article. Review.

4

Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.

Scarsella C, Alméras N, Mauriège P, Blanchet C, Sauvé L, Dewailly E, Bergeron J, Després JP. Scarsella C, et al. Among authors: despres jp. Can J Cardiol. 2003 Jan;19(1):51-7. Can J Cardiol. 2003. PMID: 12571695

5

Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.

Després JP. Després JP. Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61. doi: 10.1016/s1262-3636(03)72788-8. Diabetes Metab. 2003. PMID: 14502101 Review.

6

Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients.

Lemieux I, Salomon H, Després JP. Lemieux I, et al. Among authors: despres jp. Ann Med. 2003;35(6):442-8. doi: 10.1080/07853890310011969. Ann Med. 2003. PMID: 14572169 Free article. Clinical Trial.

7

[Obesity and cardiovascular disease].

Poirier P, Després JP. Poirier P, et al. Among authors: despres jp. Med Sci (Paris). 2003 Oct;19(10):943-9. doi: 10.1051/medsci/20031910943. Med Sci (Paris). 2003. PMID: 14613004 Free article. Review. French.

8

Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.

Blackburn P, Côté M, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Després JP. Blackburn P, et al. Among authors: despres jp. Metabolism. 2003 Nov;52(11):1379-86. doi: 10.1016/s0026-0495(03)00315-9. Metabolism. 2003. PMID: 14624394 Clinical Trial.

9

Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men.

Berthier MT, Houde A, Côté M, Paradis AM, Mauriège P, Bergeron J, Gaudet D, Després JP, Vohl MC. Berthier MT, et al. Among authors: despres jp. J Lipid Res. 2005 Feb;46(2):237-44. doi: 10.1194/jlr.M400135-JLR200. Epub 2004 Nov 16. J Lipid Res. 2005. PMID: 15547300 Free article.

10

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

Côté M, Mauriège P, Bergeron J, Alméras N, Tremblay A, Lemieux I, Després JP. Côté M, et al. Among authors: despres jp. J Clin Endocrinol Metab. 2005 Mar;90(3):1434-9. doi: 10.1210/jc.2004-1711. Epub 2004 Dec 14. J Clin Endocrinol Metab. 2005. PMID: 15598678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters